Vesilife 5mg Tablet

Vesilife 5mg Tablet contains the active ingredient Solifenacin, a muscarinic receptor antagonist belonging to the anticholinergic class of medications. It is prescribed for managing overactive bladder (OAB) symptoms, including frequent urination, urgency, and urinary incontinence. The medication works by reducing muscle overactivity in the bladder to provide symptom relief in patients with urinary disorders.

Vesilife 5mg Tablet requires careful use. Patients with severe hepatic or renal impairment, uncontrolled glaucoma, or known hypersensitivity to Solifenacin should not use this medication. Following prescribed dosage instructions and safety guidance is essential to optimise therapeutic benefit and reduce the occurrence of adverse effects.

Management of overactive bladder symptoms, including urgency and frequency. Treatment of urinary incontinence due to bladder muscle overactivity.

Solifenacin works by relaxing the smooth muscles in the bladder. It inhibits muscarinic receptors responsible for bladder contractions, thereby increasing the bladder's capacity to hold urine and reducing the urge to urinate. This action addresses both the frequency and urgency of urination, providing significant relief to patients with overactive bladder.

Dosage form : Tablet. Recommended dose : Typically one tablet daily as prescribed by a doctor. Administration : Take orally with water, with or without food. Swallow whole; do not crush or chew.

Common Side Effects Dry mouth Constipation Blurred vision Dizziness Fatigue Serious Side Effects Severe allergic reactions (swelling, difficulty breathing) Urinary retention Increased heart rate (tachycardia)

To maximise the benefits of Vesilife 5mg Tablet, adhere to your doctor’s instructions and avoid self-medication. Regular follow-ups may be necessary to monitor its efficacy and address any side effects. Stay hydrated and maintain a balanced diet to mitigate common side effects like constipation and dry mouth.